Study reveals substantial misdiagnosis of malaria in parts of Asia

July 24, 2012, British Medical Journal

Substantial overdiagnosis and mistreatment of malaria is evident in south and central Asia, warns a study published in the British Medical Journal today.

With more than two billion people at risk of malaria in this part of Asia – larger than that of Africa - this is a major public health problem which needs to be confronted, say the authors.

Malaria remains one of the most important infectious diseases of poverty. Recent global malaria treatment guidelines recommend that patients are treated with anti-malaria drugs only when a diagnostic test positively identifies malaria parasites in the patient's blood.

In Africa, however, many patients are treated for malaria even when the parasite test is negative, resulting in other severe infections being missed and drugs being wasted. Yet the extent of this problem in south and central Asia is relatively unknown.

So, a team of researchers set out to assess the accuracy of malaria and treatment for over 2,300 patients with suspected malaria at 22 clinics in northern and eastern Afganistan.

Some clinics used microscopic diagnosis, while others relied on clinical signs and symptoms to diagnose malaria.

Blood sample slides were collected for every patient as a reference slide which was read by two independent experts who recorded whether the slide was positive or negative for malaria. This reference result was compared to the result of the diagnosis at the clinic and the treatment given to each patient.

In clinics using clinical diagnosis where malaria is rare, 99% of patients with negative slides received a malaria drug and just over one in 10 (11%) received an antibiotic.

This compares with clinics using newly introduced microscopy, where 37% of negative patients received a malaria drug and 60% received an antibiotic. In clinics with established microscopy, 51% of negative received a and 27% received an antibiotic.

Almost all cases were due to vivax malaria, a relatively less serious form of malaria. However, only one in six cases of the rarer but potentially fatal falciparum malaria were detected and appropriately treated.

Compared with clinical diagnosis, microscopy improves the targeting of malaria drugs, but only by half, and it increases the prescription of antibiotics, say the authors.

They argue that misdiagnosis and treatment is caused in equal part by inaccurate microscopy and by the clinicians' tendency to treat with malaria drugs even when a test result is negative, resulting in a 40-50% loss of accuracy in treatment. The results are comparable to findings from Africa, confirming that inaccurate diagnosis and of is a worldwide problem.

However, they stress that, efforts to improve diagnostic coverage and accuracy "will be undermined without concurrent interventions to change understanding, behaviour, and practice among clinicians."

Explore further: UN appeals for $3.2 billion to meet malaria goal

More information: Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study, British Medical Journal, 2012.

Related Stories

UN appeals for $3.2 billion to meet malaria goal

April 24, 2012
(AP) -- The global campaign to fight malaria is appealing for $3.2 billion to try to reach the U.N. goal of "near-zero" deaths from the mosquito-borne disease by 2015.

Simple rapid diagnostic tests for malaria work well

July 6, 2011
When a person living in a malarial area gets a fever, health workers need to know the cause to make absolutely sure they give the right treatment. For many years in sub-Saharan Africa primary health workers have often assumed ...

Provision of subsidized malaria drugs in shops improves uptake

June 1, 2011
Reporting the findings of a cluster randomized trial carried out in rural Kenya, Beth Kangwana and colleagues find that provision of packs of the malaria therapy artemether-lumefantrine in shops at a subsidized price more ...

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.